JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (1): 80-82.doi: 10.6040/j.issn.1673-3770.0.2015.302

Previous Articles     Next Articles

Clinical analysis on intravitreal injection of conbercept in the treatment of macular edema secondary to branch retinal vein occlusion.

XING Kai1, KANG Zefeng   

  1. 1. Graduate School of Qinghai University, Xining 810016, Qinghai, China;2. Ophthalmology Clinic, Eye Hospital, China Academy of Chinese Medical Sciences, Beijing 100040, China
  • Received:2015-07-19 Online:2016-02-16 Published:2016-02-16

PDF (PC)

1105

Abstract: Objective To explore the clinical efficacy and safety of intravitreal injection of conbercept in the treatment of macular edema(ME)secondary to branch retinal vein occlusion(BRVO). Methods A total of 33 patients(38 eyes)with ME secondary to BRVO were selected as research objects, and injected Conbercept Ophthalmic Injection 0.05 mL through vitreous cavity. The optic examination was conducted at least once a month during 6-mongh follow-up. The central foveal thickness was measured to judge whether the injection was given again using optical coherence tomography(OCT). The best corrected visual acuity(BCVA)before and 1, 3 months after treatment as well as OCT results before and 1 month after treatment were compared, and the complications within 1 month after treatment were observed. Results The logarithm of minimum visual resolution(VA)was(0.59±0.21), and improved to(0.35±0.12)after the first injection(P<0.01). There was statistical significance regarding the BCVA before and 1, 3 months after treatment(P<0.05), and the BCVA 3 months after treatment was dramatically higher than that before treatment(P<0.05). The difference was statistically significant regarding the central foveal thickness of retina before and 1 month after treatment(P<0.05). Within 1 month after treatment, only 5 patients(15.15%)suffered from transient increase of intraocular pressure, no other eye-related events occurred. Conclusion For ME secondary to BRVO, intravitreal injection of conbercept based on OCT has definite short-term efficacy and better safety.

Key words: Conbercept, Macular edema, Branch retinal vein occlusion, Optical coherence tomography

CLC Number: 

  • R774
[1] 艾伦(美), 姚静. 美国威尔斯眼科医院临床眼科图谱和精要: 视网膜病[M]. 上海:上海科学技术出版社, 2005: 101.
[2] 张承芬. 眼底病学[M]. 2版.北京:人民卫生出版社, 2010: 560-575.
[3] 张菁, 蔡小军, 陈晓敏, 等. 玻璃体腔注射康柏西普联合视网膜激光光凝治疗视网膜分支静脉阻塞继发黄斑水肿疗效观察[J]. 中华眼底病杂志, 2015, 31(1):22-26. ZHANG Jing, CAI Xiaojun, CHEN Xiaomin, et al. A prospective randomized clinical trial on intravitreal injection of Conbercept combined with laser photocoagulation for macular edema secondary to branch retinal vein occlusion[J]. Chin J Ocular Fundus Dis, 2015, 31(1):22-26.
[4] Donati S, Barosi P, Bianchi M, et al. Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion[J]. Eur J Ophthalmol, 2012, 22(4):607-614.
[5] Wang Q, Li T, Wu Z, et al. Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo[J]. PLoS ONE, 2013, 8(8):e70544.
[6] Wu Z, Zhou P, Li X, et al. Structural characterization of a recombinant fusion protein by instrumental analysis and molecular modeling[J]. PLoS ONE, 2013, 8(3):e57642.
[7] 曲毅, 魏奉才. Wills眼科手册[M].5版. 济南:山东科学技术出版社, 2009: 434.
[8] 毕燃, 贾彩华, 于越, 等. 康柏西普治疗视网膜静脉阻塞黄斑水肿的临床观察[J].赤峰学院学报(自然科学版), 2014, 23:71-73. BI Ran, JIA Caihua, YU Yue, et al. Clinical observation of conbercept in the treatment of patients with macular edema secondary to branch retinal vein occlusion[J]. J Chifeng Univ(Nat Sci Ed), 2014, 23:71-73.
[9] Chen C H, Chen Y H, Wu P C, et al. Treatment of branch retinal vein occlusion induced macular edema in treatment-naive cases with a single intravitreal triamcinolone or bevacizumab injection[J]. Chang Gung Med J, 2010, 33(4):424-435.
[10] Feng J, Zhao T, Zhang Y, et al. Differences in aqueous concentrations of cytokines In macular edema secondary to branch and central retinal vein occlusion[J]. PLoS ONE, 2013, 8(7):e68149.
[11] Pielen A, Mirshahi A, Fehgen N, et al. Ranibizumab for branch retinal vein occlusion associated macular edema study(RABAMES): six-month results of a prospective randomized clinical trial[J]. Acta Ophthalmol, 2015, 93(1):e29-37.
[12] Tsagkataki M, Papathomas T, Lythgoe D, et al. Twenty-four-month results of intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion[J]. Semin Ophthalmol, 2015, Aug 21:1-8, [Epub ahead of print].
[13] Hikichi T, Higuchi M, Matsushita T, et al. Two-year outcomes of intravitreal bevacizumab therapy for macular edema secondary to branch retinal vein occlusion[J]. Br J Ophthalmol, 2014, 98(2):195-199.
[14] 舒智宇. 康柏西普治疗视网膜静脉阻塞黄斑水肿的临床分析[J]. 延边医学, 2015, 12:47-48. SHU Zhiyu. Clinical analysis of conbercept for treating macular edema secondary to branch retinal vein occlusion[J]. Yanbian Med J, 2015, 12:47-48.
[1] ZHU Mingqiong, LI Zheng, LIU Ru, TIAN Tao, PENG Jingli, LYU Qianyi, TAN Huaxia. The application of AI screening system based on OCT/OCTA in the evaluation of the effect of anti VEGF treatment in patients with diabetes macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 68-73.
[2] SUN Qingzhu, SHEN Jian, CHEN Xing, WU Yanbing, ZENG Lun. The role of metabolic indicators in predicting ranibizumab efficacy in diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 74-81.
[3] ZHU Yunlong, WANG Ping, GAO Meng. A case of posterior scleritis initially misdiagnosed as central serous chorioretinopathy and retinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 99-105.
[4] LI Shiqiang, MA Yan, WANG Jiawei. Advances in clinical applications of optical coherence tomography angiography in systemic diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 127-134.
[5] DING Shuliang, WANG Chaofan, LIU Jianliang. A case of intraocular fluid detection to guide precise treatment of acute retinal necrosis and review of the literature [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 114-117.
[6] ZHANG Lu, WANG Yongjing, JIA Jun, ZHAO Jiannan, ZHAO Fang. Spectral domain optical coherence tomography imaging characteristics in patients with initial onset floaters [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 85-88.
[7] HUANG Jiao, PENG Changfu. Progress in objective evaluation of thyroid-related eye disease activity [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 171-178.
[8] SHEN Jiaqi, LI Xiaosa, BI Yanlong, ZHANG Jingfa. The application of artificial intelligence in screening, diagnosis and prognosis of diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 153-159.
[9] MA Jiling, WANG Xiaoming, LI Yan, MU Yanxiao, JIN Lin, KONG Hui, YANG Naifu, DANG Guangfu. Evaluation of three different aspheric intraocular lens tilts and decentrations in capsular bags after cataract surgery based on CASIA2 [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 76-85.
[10] BAO Ying, LIU Zhigao, JANG Pengfei, CUI Wenxuan, ZHENG Xiaoxia, YANG Mengyao, SI Mingwei, WANG Yu, WANG Hong. Clinical observation of compacept in the treatment of diabetes mellitus with CRVO-ME high reflex point [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 55-60.
[11] CHANG Weiwei, JIAO Wanzhen, CUI Yanyan, ZHAO Jie, LIU Zhaoqiang, ZHAO Bojun. Research progress of diabetic macular ischaemia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 130-136.
[12] ZHOU Jinglin, LI Jinxiang, ZENG Qi. Effect of 577 nm subthreshold micropulse laser photocoagulation combined with anti-VEGF on the treatment of refractory diabetic macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 18-25.
[13] HE Jing, LEI Chunyan, ZHANG Meixia. Association of glycosylated hemoglobin variation index with diabetic retinopathy severity [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 34-40.
[14] WU Lili, QU Yi. Application of optical tomography angiography and artificial intelligence in choroidal neovascularization secondary to pathologic myopia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 144-149.
[15] WANG Xinyu, GAO Lifen, LU Hui, SONG Wenqi, YANG Yu. Related retinal manifestations in Parkinson's disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 156-162.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd